Skip to main content
. Author manuscript; available in PMC: 2011 Oct 11.
Published in final edited form as: Mol Cancer Res. 2007 Oct;5(10):1053–1062. doi: 10.1158/1541-7786.MCR-07-0145

FIGURE 2.

FIGURE 2

PU.1 siRNA treatment suppresses PU.1 protein levels and induces hemoglobin expression. GATA-1-ER MEL cells were treated with 10−7 mol/L of β-estradiol or transiently transfected with a double-stranded PU.1 siRNA or control siRNA at the concentrations indicated for 26 h. Cell extracts were prepared by sonication, separated by SDS-PAGE, and immunoblotted for PU.1 (20 µg/lane; A) or hemoglobin (9 µg/lane; B). C. Quantitation of PU.1 and hemoglobin immunoblot band intensities.